Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Multiple functional implications have been suggested for a limited number of chemokines and their cognate receptors in melanoma pathogenesis. The purpose of this study was to investigate the potential role of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 as prognostic markers in human primary cutaneous melanoma. Chemokine receptor expression was analyzed by immunohistochemistry in a total of 38 patients with cutaneous melanoma. Results were statistically correlated with melanoma features and clinical disease progression. No significant correlation between overexpression of CXCR4 or CCR9 and survival or prognosis was found. CCR7 overexpression was associated with significantly lower survival (0.005 log rank) and shorter time to progression (0.009 log rank)—similar to CCR10 overexpression (lower survival: 0.001 log rank, shorter time to progression: 0.002 log rank). In addition, CCR7 overexpression correlated with expression of metallothionein, while CCR10 seems to be associated with cerebral metastases. Two chemokine receptors permitting the identification of high-risk patients were identified: CCR7 and CCR10 overexpressions were found to be associated with a worse outcome of disease course independent of Breslow’s tumor thickness and Clark level, thus representing possible additional prognostic markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, Faries MB, Morton DL, Hoon DS (2008) Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res 14(3):638–645

    Article  PubMed  CAS  Google Scholar 

  2. Bartolomé RA, Gálvez BG, Longo N, Baleux F, Van Muijen GN, Sánchez-Mateos P, Arroyo AG, Teixidó J (2004) Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res 64(7):2534–2543

    Article  PubMed  Google Scholar 

  3. Förster R, Ohl L, Henning G (2001) Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma. J Natl Cancer Inst 93(21):1588–1589

    Article  PubMed  Google Scholar 

  4. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Müller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99(1):23–33

    Article  PubMed  Google Scholar 

  5. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Müller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, Ruzicka T, Lehmann P, Oldham E, Zlotnik A (2000) Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164(7):3465–3470

    PubMed  CAS  Google Scholar 

  6. Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G (2006) Human melanoma metastases express functional CXCR4. Clin Cancer Res 12(8):2427–2433

    Google Scholar 

  7. Hwang ST (2004) Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J Invest Dermatol 122(3):14–15

    Article  Google Scholar 

  8. Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS (2006) Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 244(1):113–120

    Article  PubMed  Google Scholar 

  9. Letsch A, Keilholz U, Schadendorf D, Assfalg G, Asemissen AM, Thiel E, Scheibenbogen C (2004) Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 122(3):685–690

    Article  PubMed  CAS  Google Scholar 

  10. Li H, Alizadeh H, Niederkorn JY (2008) Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci 49(2):636–643

    Article  PubMed  Google Scholar 

  11. Monteagudo C, Martin JM, Jorda E, Llombart-Bosch A (2007) CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors. J Clin Pathol 60(6):596–599

    Article  PubMed  CAS  Google Scholar 

  12. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM, Zlotnik A (1999) CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 96(25):14470–14475

    Article  PubMed  CAS  Google Scholar 

  13. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56

    Article  PubMed  Google Scholar 

  14. Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, Castillo SS, Dennis PA, Hwang ST (2003) Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198(9):1337–1347

    Article  PubMed  CAS  Google Scholar 

  15. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, Hwang ST (2002) Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62(24):7328–7334

    PubMed  CAS  Google Scholar 

  16. Navarini-Meury AA, Conrad C (2009) Melanoma and innate immunity—active inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. Semin Cancer Biol 19(2):84–91

    Article  PubMed  CAS  Google Scholar 

  17. Payne AS, Cornelius LA (2002) The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118(6):915–922

    Article  PubMed  CAS  Google Scholar 

  18. Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256(2):137–165

    Article  PubMed  CAS  Google Scholar 

  19. Richmond A (2008) CCR9 homes metastatic melanoma cells to the small bowel. Clin Cancer Res 14(3):621–623

    Article  PubMed  CAS  Google Scholar 

  20. Richmond A, Yang J, Su Y (2009) The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res 22(2):175–186

    Article  PubMed  CAS  Google Scholar 

  21. Scala S, Ieranò C, Ottaiano A, Franco R, La Mura A, Liguori G, Mascolo M, Staibano S, Ascierto PA, Botti G, De Rosa G, Castello G (2007) CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol Immunother 56(10):1589–1595

    Article  PubMed  CAS  Google Scholar 

  22. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11(5):1835–1841

    Article  PubMed  CAS  Google Scholar 

  23. Simonetti O, Goteri G, Lucarini G, Filosa A, Pieramici T, Rubini C, Biagini G, Offidani A (2006) Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur J Cancer 42(8):1181–1187

    Article  PubMed  CAS  Google Scholar 

  24. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS (2004) CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10(7):2351–2358

    Article  PubMed  CAS  Google Scholar 

  25. Varney ML, Johansson SL, Singh RK (2006) Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol 125(2):209–216

    PubMed  CAS  Google Scholar 

  26. Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L (2005) Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine 29(2):49–55

    Article  PubMed  CAS  Google Scholar 

  27. Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO, Zelger B (2006) Metallothionein—overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br J Cancer 27(6):835–841

    Article  Google Scholar 

Download references

Acknowledgments

We thank Birgit Peer, Nadja Greier and Margit Abenthung for excellent technical assistance. This work was supported by Oncotyrol—Center for Personalized Cancer Medicine (project 1.3, Cell Therapy Unit).

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Dermatology, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria

    Laura Kühnelt-Leddihn, Hansgeorg Müller, Bernhard Zelger & Georg Weinlich

  2. Department of Dermatology, Central Hospital Bolzano, Bolzano, Italy

    Klaus Eisendle

Authors
  1. Laura Kühnelt-Leddihn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hansgeorg Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Klaus Eisendle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernhard Zelger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Georg Weinlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hansgeorg Müller.

Additional information

L. Kühnelt-Leddihn and H. Müller contributed equally to this work.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kühnelt-Leddihn, L., Müller, H., Eisendle, K. et al. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?. Arch Dermatol Res 304, 185–193 (2012). https://doi.org/10.1007/s00403-012-1222-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1222-8

Keywords

Search

Navigation